Androgen receptor and estrogen receptor imaging in patients with metastatic breast cancer.

被引：1
|
作者：
Venema, Clasina Marieke
Mammatas, Lemonitsa H.
van Kruchten, Michel
Apollonio, Giulia
Schroder, Carolina Pia
Glaudemans, Andor W. J. M.
Hoekstra, Otto S.
Verheul, Henk M. W.
van der Vegt, Bert
De Vries, Erik F. J.
De Vries, Elisabeth
Menke, Catharina Wilhelmina
Hospers, Geke
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[3] Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands
[4] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands
[5] Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.11553
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11553
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies
    Venema, Clasina M.
    Mammatas, Lemonitsa H.
    Schroeder, Carolina P.
    van Kruchten, Michel
    Apollonio, Giulia
    Glaudemans, AndorW. J. M.
    Bongaerts, Alfons H. H.
    Hoekstra, Otto S.
    Verheul, Henkm. W.
    Boven, Epi
    van der Vegt, Bert
    de Vries, Erik F. J.
    de Vries, Elisabeth G. E.
    Boellaard, Ronald
    van Oordt, Catharina W. Menke van der Houven
    Hospers, Geke A. P.
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (12) : 1906 - 1912
  • [2] Estrogen receptor and progesterone receptor status: differences between primary and metastatic breast cancer.
    Glass, EL
    Heffelfinger, S
    Blau, R
    Lower, EE
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S60 - S60
  • [3] Estrogen receptor negative breast cancer.
    Mccaskill-Stevens, W
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1257S - 1257S
  • [4] Estrogen receptor beta in breast cancer.
    Gustafsson, JA
    Warner, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2785S - 2786S
  • [5] Palbociclib's effect on estrogen receptor mutations in metastatic breast cancer.
    Kota, Karthik Joshua
    Gyanchandani, Rekha
    Brufsky, Adam
    Lee, Adrian V.
    Oesterreich, Steffi
    Puhalla, Shannon
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Breast cancer:: from estrogen to androgen receptor
    Andò, S
    De Amicis, F
    Rago, V
    Carpino, A
    Maggiolini, M
    Panno, ML
    Lanzino, M
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 193 (1-2) : 121 - 128
  • [7] Tumor imaging with the estrogen receptor radioligand Z-[I-123]MIVE in patients with metastatic breast cancer.
    Rijks, LJM
    Bakker, PJM
    Veenhof, CHN
    Boer, GJ
    deBruin, K
    Janssen, AGM
    vanRoyen, EA
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (10) : 1835 - 1835
  • [8] Risk factors for estrogen receptor positive and estrogen receptor negative breast cancer.
    Rosner, BA
    Colditz, GA
    Chen, WY
    Holmes, MD
    Hankinson, SE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (11) : S40 - S40
  • [9] Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
    Gucalp, Ayca
    Tolaney, Sara
    Isakoff, Steven J.
    Ingle, James N.
    Liu, Minetta C.
    Carey, Lisa A.
    Blackwell, Kimberly
    Rugo, Hope
    Nabell, Lisle
    Forero, Andres
    Stearns, Vered
    Doane, Ashley S.
    Danso, Michael
    Moynahan, Mary Ellen
    Momen, Lamia F.
    Gonzalez, Joseph M.
    Akhtar, Arooj
    Giri, Dilip D.
    Patil, Sujata
    Feigin, Kimberly N.
    Hudis, Clifford A.
    Traina, Tiffany A.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5505 - 5512
  • [10] Investigation of estrogen receptor phosphorylation in breast cancer.
    Sarwar, N.
    Jiang, J.
    Shousha, S.
    Coombes, R. C.
    Ali, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S163 - S163
12345